Clinical trial
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
NCT02235077
Study timeline
Study start (actual)2014-12-30Date precision: day
Registry last updated2017-06-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Interventions
SpironolactoneDRUG · verified · RxNorm: spironolactone
PlaceboDRUG
Sponsors & collaborators
Duke Universitylead sponsor
Mapped research locations
BostonMassachusetts, United States3ClevelandOhio, United States3PhiladelphiaPennsylvania, United States2St LouisMissouri, United States2Salt Lake CityUtah, United States2HoustonTexas, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1DurhamNorth Carolina, United States1RochesterMinnesota, United States1BurlingtonVermont, United States1Stony BrookNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02235077 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.